Speakers 2020 Speakers Amy Abernethy, MD, PhD Principal Deputy Commissioner & Acting CIO, U.S. Food and Drug Administration Amy Abernethy, MD, PhD Principal Deputy Commissioner & Acting CIO, U.S. Food and Drug Administration Amy P. Abernethy, M.D., Ph.D. is an oncologist and internationally recognized clinical data expert and clinical researcher. As the Principal Deputy Commissioner of Food and Drugs, Dr. Abernethy helps oversee FDA’s day-to-day functioning and directs special and high-priority cross-cutting initiatives that impact the regulation of drugs, medical devices, tobacco and food. As acting Chief Information Officer, she oversees FDA’s data and technical vision, and its execution. She has held multiple executive roles at Flatiron Health and was professor of medicine at Duke University School of Medicine, where she ran the Center for Learning Health Care and the Duke Cancer Care Research Program. Dr. Abernethy received her M.D. at Duke University, where she did her internal medicine residency, served as chief resident, and completed her hematology/oncology fellowship. She received her Ph.D. from Flinders University, her B.A. from the University of Pennsylvania and is boarded in palliative medicine. Stacey Allaster Chief Executive, Professional Tennis, USTA Stacey Allaster Chief Executive, Professional Tennis, USTA Stacey Allaster is an internationally renowned sports and entertainment leader, champion of equality and innovator in the sport of tennis. Currently, Stacey is the United States Tennis Association’s Chief Executive, Professional Tennis, responsible for setting the strategic vision for the USTA’s pro tennis division, including oversight of the US Open, US Open Series, Davis Cup and Fed Cup, the professional developmental pathway for aspiring young Americans and Officiating. Under Stacey's leadership, the USTA leverages professional tennis tournaments and assets to inspire kids and adults to be physically active, play tennis and lead healthy lifestyles. Previously, Stacey was the Tournament Director of the Canadian Open (now known as the Rogers Cup), where she was the only woman tournament director within the ATP Master Series. In 2006, she was hired as the President of the WTA, and three years later was promoted to Chairman and CEO. During her tenure, Stacey generated $1 billion in revenue, while expanding the global footprint of women’s professional tennis, including a robust Asia-Pacific growth strategy. Throughout her career, Stacey has been a fierce advocate for equality in women’s sports, playing a lead role in driving prize money growth and securing equal prize money for women at Wimbledon, Roland Garros and WTA major events. Additionally, she has dedicated her personal life and career to inspiring and mentoring the next generation of strong and confident female leaders. Stacey has been named one of the Top 50 Heroes of Tennis in the past 50 years in Tennis Magazine, the WISE Woman of the Year and a Sports Business Journal Gamechanger. She was also recognized by Forbes as one of the 10 Most Powerful Women in Sports. Anousheh Ansari, PhD CEO, XPRIZE Anousheh Ansari, PhD CEO, XPRIZE Anousheh Ansari is a CEO of the XPRIZE Foundation, the world’s leader in designing and operating incentive competitions to solve humanity’s grand challenges. Ansari, along with her family, sponsored the organization’s first competition, the Ansari XPRIZE, a $10 million competition that ignited a new era for commercial spaceflight. Since then, she has served on XPRIZE’s Board of Directors. Prior to being named CEO of XPRIZE, Ansari served as the CEO of Prodea Systems, a leading Internet of Things (IoT) technology firm she co-founded in 2006, and continues to serve as the executive chairwoman. She captured headlines around the world when she embarked upon an 11-day space expedition, accomplishing her childhood dream of becoming the first female private space explorer, first astronaut of Iranian descent, first Muslim woman in space, and fourth private explorer to visit space. Ansari serves on the World Economic Forum’s (WEF) Global Future Council and has received numerous honors, including the WEF Young Global Leader, Ellis Island Medal of Honor, and STEM Leadership Hall of Fame, among others. She is a UNESCO Good Will Ambassador and serves on the board of Jabil and Peace First, as well as several other not-for-profit organizations focused on STEM education and youth empowerment. Ansari also co-founded The Billion Dollar Fund for Women, announced at the Tri Hita Karana (THK) Forum on Sustainable Development in Bali, Indonesia, with a goal of investing $1 billion in women-founded companies by 2020. She published her memoir, My Dream of Stars, to share her life story as inspiration for young women around the world.??Ansari holds a BS in electronics and computer engineering from George Mason University, an MS in electrical engineering from George Washington University; and honorary doctorates from George Mason University, Utah Valley University, and International Space University. Jeff Arnold Founder, Chairman & CEO, Sharecare Jeff Arnold Founder, Chairman & CEO, Sharecare Jeff Arnold is chairman and CEO of Sharecare, a digital health company he founded with Dr. Oz to help each person – no matter where they are in their health journey – build a longer, better life by enabling health transformation at the individual, organizational and community level. Also chairman of Forbes Travel Guide, he was twice named EY Entrepreneur Of The Year – in 1999 for WebMD and 2019 for Sharecare – making him one of a handful of winners in history to receive the award twice. Dotsie Bausch Olympic Silver Medalist, London 2012; Founder, Switch for Good Dotsie Bausch Olympic Silver Medalist, London 2012; Founder, Switch for Good After concluding a prolific professional cycling career that produced a medal at the 2012 London Olympic Games, eight US national championships, two Pan American gold medals and a world record, Dotsie Bausch has become a powerful influencer for plant-based eating for athletes and non-athletes alike. Named by VegNews in 2019 as one of the top 20 most influential vegans in the world, she utilizes her degree in plant-based nutrition to inform her impassioned messages as an advocate on behalf of humans, planet earth and animals. Dotsie latest initiative is founding the non-profit Switch4Good. Switch4Good launched in” – early 2018 with a television commercial featuring six Olympians from four different countries and proves that cow’s milk is not part of a high-performance diet. Bausch is also one of the stars of the film The Game. Changers (http://gamechangersmovie.com), which chronicles the story of the world’s most dangerous myth. Directed by Academy Award winner Louie Psihoyos and executive produced by Oscar winner James Cameron, The Game Changers released to worldwide audiences in October of 2019 and in just one week, became the #1 downloaded film of all time on iTunes. Long before embodying radiant health and becoming an influential game changer, Bausch struggled for years with severe eating disorders and a recreational drug habit, that combined, led to a suicide attempt. It was during her recovery that she discovered her gift and love for the bike. Bausch speaks passionately around the world, spreading her message about the numerous benefits – humane, nutritional and environmental – of plant-based eating. Her popular TEDx Talk, “Olympic Level Compassion,” has garnered over 275,000 views and has been a catalyst of change for thousands of people. Holly Benson EVP, CEO & President Health Care Enterprises, Centene Holly Benson EVP, CEO & President Health Care Enterprises, Centene Holly Benson serves as EVP, President and CEO of Health Care Enterprises where she oversees the operations of Community Medical Group, HealthSmart, Interpreta, and USMM. Centene owns all or a portion of each of those companies, and Holly is responsible for ensuring that those companies not only provide quality service to Centene’s health plans but also to external customers and that those companies continue to grow and develop innovative new products and services. Holly joined Centene in March 2011 as Centene’s Senior Vice President of Health Policy. Ms. Benson graduated with honors from Dartmouth College and earned her law degree from the University of Florida - College of Law. Elizabeth Bradley, PhD President, Vassar College Elizabeth Bradley, PhD President, Vassar College Elizabeth H. Bradley, PhD, was named the 11th President of Vassar College in July 2017. Prior to this position, she was on the faculty at Yale for more than twenty years, and was most recently the Brady-Johnson Professor of Grand Strategy and Faculty Director of the Yale Global Health Leadership Institute. She also served as the Head of College for Yale’s Branford College. Bradley is renowned internationally for her work on quality of hospital care and large-scale health system strengthening efforts within the US and abroad including in China, India, Ethiopia, Liberia, Ghana, Rwanda, and the United Kingdom. In the US, Bradley published the landmark papers that drove national change in the care of patients with heart attacks, and in Ethiopia, Bradley is widely known as a major architect of the system-wide improvements in the quality of health care provided to the 90 million people of that country. Bradley has published more nearly 320 peer-reviewed papers and has co-authored three books including The American Healthcare Paradox: Why Spending More Is Getting Us Less. She is the 2018 recipient of the William B. Graham Prize for Health Services Research, the highest distinction that researchers in the health services field can achieve. Bradley was elected to the National Academy of Medicine in 2017. Bradley graduated phi beta kappa from Harvard in economics magna cum laude, earned an MBA from the University of Chicago, and a PhD in health economics from Yale University. Bradley grew up in New Britain, Connecticut and is married to her husband John with whom she has three adult children. Dale E. Bredesen, MD Professor, UCLA • Founding President & Professor Emeritus, Buck Institute for Research on Aging Dale E. Bredesen, MD Professor, UCLA • Founding President & Professor Emeritus, Buck Institute for Research on Aging Dr. Bredesen received his undergraduate degree from Caltech and his medical degree from Duke. He served as Resident and Chief Resident in Neurology at UCSF, then was postdoctoral fellow in the laboratory of Nobel laureate Prof. Stanley Prusiner. He was a faculty member at UCLA from 1989-1994, then was recruited by the Burnham Institute to direct the Program on Aging. In 1998 he became the Founding President and CEO of the Buck Institute for Research on Aging, and Adjunct Professor at UCSF; then in 2013 he returned to UCLA as the Director of the Easton Center for Alzheimer’s Disease Research. The Bredesen Laboratory studies basic mechanisms underlying the neurodegenerative process, and the translation of this knowledge into effective therapeutics for Alzheimer’s disease and other neurodegenerative conditions, leading to the publication of over 220 research papers. He established the ADDN (Alzheimer’s Drug Development Network) with Dr. Varghese John in 2008, leading to the identification of new classes of therapeutics for Alzheimer’s disease. He and his group developed a new approach to the treatment of Alzheimer’s disease, and this approach led to the discovery of subtypes of Alzheimer’s disease, followed by the first description of reversal of symptoms in patients with MCI and Alzheimer’s disease, with the ReCODE (reversal of cognitive decline) protocol, published in 2014, 2016, and 2018. His book, The End of Alzheimer’s, is a New York Times Bestseller. John Hope Bryant Founder, Chairman and CEO, Operation HOPE, Inc John Hope Bryant Founder, Chairman and CEO, Operation HOPE, Inc John Hope Bryant is an American entrepreneur, author, philanthropist, and prominent thought leader on financial inclusion, economic empowerment and financial dignity. He has served as an advisor to the last three sitting U.S. presidents, from both political parties. He is responsible for financial literacy becoming the policy of the U.S. federal government. Additionally, Bryant is a permanent part of the Smithsonian AFRICAN-American Museum. He is named one of Atlanta Business Chronicle’s “Most Admired CEOs” in 2018, American Banker magazine “Innovator of the Year” in 2016, Inc. Magazine “The World’s 10 Top CEOs”, and in 1994 Time magazine’s “50 Leaders for the Future”. Howard A. Burris III, MD, FASCO, FACP President & Chief Medical Officer, Sarah Cannon Research Institute Howard A. Burris III, MD, FASCO, FACP President & Chief Medical Officer, Sarah Cannon Research Institute Howard A. "Skip" Burris III, MD, FASCO, FACP serves as president and chief medical officer of Sarah Cannon, as well as the executive director, drug development for the research institute. He is an associate of Tennessee Oncology, PLLC, where he practices medical oncology. Barry Byrne, MD, PhD Professor & Associate Chair, University of Florida Barry Byrne, MD, PhD Professor & Associate Chair, University of Florida Dr. Barry Byrne is a clinician scientist who is studying a variety of rare diseases withthespecificgoalofdevelopingtherapiesforinheritedmuscle disease. Asa pediatric cardiologist, his focus is on conditions that lead to skeletal muscle weaknessandabnormalitiesinheartandrespiratory function. Hisgrouphas made significant contributions to the understanding and treatment of Pompe disease, a type of neuromuscular disease due to glycogen storage in motor units. Theresearchteamhas beendevelopingnewtherapiesusingAAV-mediatedgene therapy to restore cardiac and skeletal muscle function in DMD, Friedreich’s ataxia, Pompe, and other inherited neuromuscular diseases. His group at the Powell Center has also established a series of new methods for large-scale AAV clinical manufacturing. The work is supported by several NIH and foundation awards. Dr. Byrne is the Associate Chair of Pediatrics and Director of the University of Florida Powell Center and Child Health Research Institute. He obtained his B.S. degree from Denison University; M.D. and Ph.D. from the University of Illinois; and hecompleted hisPediatricsresidencyandcardiologyfellowshipaswellaspost- doctoral training in Biological Chemistry at the Johns Hopkins Hospital. Following his early career at Hopkins, he joined the University of Florida and is now the Earl and Christy Powell University Chair in Genetics. In addition to his academic appointments, he serves as the Chief Medical Advisor of the Muscular Dystrophy Association and a member of the TACT committee of TREAT-NMD. He is an advisor to the Pfizer Rare Disease Therapeutic Area Advisory Committee and co-founder of AavantiBio. Richard Carmona, MD, MPH, FACS 17th Surgeon General of the United States • Chief of Health Innovations, Canyon Ranch • Distinguished Professor, University of Arizona • Chairman, Lake Nona Impact Forum, Advisory Board Richard Carmona, MD, MPH, FACS 17th Surgeon General of the United States • Chief of Health Innovations, Canyon Ranch • Distinguished Professor, University of Arizona • Chairman, Lake Nona Impact Forum, Advisory Board Born to a poor immigrant family in New York City, Richard Carmona experienced homelessness, hunger, and health disparities during his youth. The experiences greatly sensitized him to the relationships among culture, health, education and economic status and ultimately shaped his future. After dropping out of high school, Dr. Carmona enlisted in the U.S. Army in 1967 where he received a GED. By the time he left active duty, he was a Special Forces, combat-decorated Vietnam veteran. He then pursued a college degree and entered medical school at the University of California – San Francisco where he won the prestigious Gold Cane award as the top graduate. Dr. Carmona became a surgeon with a sub-specialty in trauma, burns and critical care and was recruited to Tucson to establish the first trauma system in southern Arizona which he did successfully. Later, while working full time as a hospital and health system CEO, he earned a master’s degree in public health policy and administration at the University of Arizona. Dr. Carmona has served for over 32 years with the Pima County Sheriff’s Department in Tucson, including as deputy sheriff, detective, SWAT team leader and department surgeon. He is one of the most highly decorated police officers in Arizona, and his numerous awards include the National Top Cop Award, the National SWAT Officer of the Year, and the National Tactical EMS Award. Dr. Carmona is a nationally recognized SWAT expert and has published extensively on SWAT training and tactics, forensics, and tactical emergency medical support. Dr. Carmona has also served as a medical director of police and fire departments and is a fully qualified peace officer with expertise in special operations and emergency preparedness, including weapons of mass destruction. In 2006 Vice Admiral Carmona successfully completed the statutory four-year term as Surgeon General and was named vice chairman of Canyon Ranch, CEO of the health division and president of the Canyon Ranch Institute. Dr. Carmona continues his Canyon Ranch leadership role as the Chief of Health Innovations. He also serves on several corporate boards and works with private equity and venture capital firms to identify emerging science and technology to translate to market for economic and public benefit. Gloria A. Caulfield Vice President, Strategic Alliances, Tavistock • Co-Founder & Executive Director, Lake Nona Impact Forum Gloria A. Caulfield Vice President, Strategic Alliances, Tavistock • Co-Founder & Executive Director, Lake Nona Impact Forum Gloria Caulfield leads health and wellness strategy and planning for the Lake Nona Institute. Gloria is passionate about identifying partners who are skillful at collaboration and have the desire to innovate solutions that have the potential to move the needle on community health and wellness. Deepak Chopra MD, FACP Co-Founder Chopra Foundation • Chairman Chopra Global Deepak Chopra MD, FACP Co-Founder Chopra Foundation • Chairman Chopra Global Deepak Chopra MD, FACP, founder of The Chopra Foundation and founder of Chopra Global and cofounder of Jiyo.com, is a world-renowned pioneer in integrative medicine and personal transformation. He is the author of over 86 books translated into over forty-three languages, including numerous New York Times bestsellers. His national bestseller, Metahuman: Unleashing Your Infinite Potential, unlocks the secrets to moving beyond our present mental and physical limitations to access a field of infinite possibilities that can radically change everything in our lives. TIME magazine has described Dr. Chopra as "one of the top 100 heroes and icons of the century." Dr. Chopra is Board Certified in Internal Medicine, Endocrinology and Metabolism, a Fellow of the American College of Physicians, and a member of the American Association of Clinical Endocrinologists. He serves as a Clinical Professor of Family Medicine and Public Health at the University of California, San Diego, and hosts the #1 health and wellbeing podcasts Deepak Chopra's Infinite Potential and Daily Breath. The World Post and The Huffington Post global internet survey ranked “Chopra #17 influential thinker in the world and #1 in Medicine.” Toby Cosgrove, MD Executive Advisor, Cleveland Clinic • Executive Advisor, Healthcare & Life Sciences, Google Cloud Toby Cosgrove, MD Executive Advisor, Cleveland Clinic • Executive Advisor, Healthcare & Life Sciences, Google Cloud Toby Cosgrove, MD, is Executive Advisor and former CEO and president of Cleveland Clinic. Serving from 2004 through 2017, he led the $8 billion organization to new heights of achievement and efficiency, seeing it ranked the #2 hospital in America (U.S. News). In his role as Executive Advisor, he is working with Cleveland Clinic leadership on strategies for national and international growth. Additionally, he is Executive Advisor, Healthcare & Life Sciences for Google Cloud. Dr. Cosgrove graduated from Williams College and the University of Virginia School of Medicine. He trained at Massachusetts General Hospital and Brook General Hospital in London. In 1967, he was a surgeon in the U.S. Air Force, earning a Bronze Star. Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the Department of Thoracic and Cardiovascular surgery from 1989 to 2004. He performed over 22,000 operations and earned an international reputation in valve repair He holds 30 patents for medical innovations. As CEO from 2004 to 2017, he reorganized services, improved outcomes and patient experience, and strengthened the organization’s finances. He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues. John F. Crowley Chairman & CEO, Amicus Therapeutics John F. Crowley Chairman & CEO, Amicus Therapeutics John F. Crowley is the Chairman and CEO of Amicus Therapeutics, a global biotechnology company focusing on developing treatments for rare genetic diseases. John has been Amicus CEO since 2005 and has overseen the company’s growth from a four person start-up to one with operations in more than 30 countries, with 550+ employees and a market value of nearly $3 Billion. John’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular disorder. In his drive to find a cure for them, he left his position at Bristol-Myers Squibb and became an entrepreneur as the Co-founder, President and CEO of Novazyme Pharmaceuticals, a biotech start-up conducting research on a new experimental treatment for Pompe disease (which he credits as ultimately saving his children's lives). In 2001, Novazyme was acquired by Genzyme Corporation and John continued to play a lead role in the development of a drug for Pompe disease as Senior Vice President, Genzyme Therapeutics. John and his family have been profiled on the front page of The Wall Street Journal and are the subjects of a book by Pulitzer prize-winning journalist Geeta Anand, "The Cure: How a Father Raised $100 Million-And Bucked the Medical Establishment-In a Quest to Save His Children." The major motion picture, Extraordinary Measures, starring Brendan Fraser and Harrison Ford, is inspired by the Crowley family journey. John is the author of a personal memoir: Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. John served as a commissioned intelligence officer in the U.S. Navy Reserve from 2005-2016, assigned to the United States Special Operations Command and is a veteran of the global war on terrorism, with service in Afghanistan. He graduated with a B.S. in Foreign Service from Georgetown University, and earned a J.D. from the University of Notre Dame Law School and an M.B.A. from Harvard. The Crowley family was the recipient of the 2011 Family Exemplar Award from the University of Notre Dame. He is also a member of the University Council on Science & Technology at Notre Dame. John served as the National Chairman of the Make-A-Wish Foundation of America (2014-2016) and is a founding Board member of the Global Genes Project. John is a Henry Crown Fellow at the Aspen Institute. Karen Dale, RN, MSN Market President & CEO, AmeriHealth Caritas District of Columbia Karen Dale, RN, MSN Market President & CEO, AmeriHealth Caritas District of Columbia Karen Dale is the CEO for AmeriHealth Caritas District of Columbia, which serves more than 120,000 members. Guided by the organization's mission and values as well as the strategies of innovation and collaboration, she is implementing population health approaches, leading policy change and creating a more human-centered system of care. Her career includes working in public health, and hospital systems. Lynda Deakin Partner & Managing Director, IDEO Lynda Deakin Partner & Managing Director, IDEO Lynda Deakin is a partner and managing director at IDEO. With over 20 years of experience in human centered design, she focuses on driving change in the food and health systems to enable better care and choices for people and the planet. Lynda works across the food and healthcare industries and uses design as a tool to help individuals, organizations, and society establish healthier, more sustainable behaviors. She has spoken on this topic and more at the Danone 100 Years event and the Culinary Institute of America and MIT Media Lab’s ReThink Food conference, and served as a judge for the Basque Culinary World Prize. Lynda’s empathic approach and charismatic leadership enables clients to address customer and patient desires and tackle a wide variety of challenges, from embracing the circular economy of food and bringing healthcare to the underserved to transforming food at scale and building disruptive new health ventures. Lynda has collaborated with large companies and organizations as well as smaller startups and foundations that are on a mission to reshape the future of food and health, including Revolution Foods, Nestle, The J.M. Smucker Company, Habit, Del Monte Foods, and the Basque Culinary Center. Lord Michael Dobbs Novelist • Member of the House of Lords Lord Michael Dobbs Novelist • Member of the House of Lords Lord Michael Dobbs is Britain’s foremost parliamentary novelist and an active member of the House of Lords. He is best known for writing House of Cards, now a global TV hit with Netflix, based on his experience as Margaret Thatcher’s chief of staff. He has written award-winning novels about Winston Churchill and has a doctorate in international affairs. Victor Dzau, MD President, National Academy of Medicine Victor Dzau, MD President, National Academy of Medicine Victor J. Dzau is the President of the US National Academy of Medicine (NAM). In addition, he serves as Vice Chair of the US National Research Council. He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Emmeline Edwards, PhD Director, National Center for Complementary Integrative Health, Division of Extramural Research Emmeline Edwards, PhD Director, National Center for Complementary Integrative Health, Division of Extramural Research Dr. Emmeline Edwards is director of the Division of Extramural Research of the National Center for Complementary and Integrative Health (NCCIH). In that capacity, she is responsible for development of scientific programs or areas of science that fulfill NCCIH's mission as well as planning, implementation and policy. NCCIH is one of 27 components of the National Institutes of Health (NIH), with a mission to define, through rigorous scientific investigation, the usefulness and safety of complementary and alternative medicine interventions and their roles in improving health and health care. Before coming to NIH, Dr. Edwards earned her Ph.D. in Neurochemistry from Forham University, did postdoctoral research in behavioral pharmacology and neuroscience at the State University of New York, and was a tenured Associate Professor in the Department of Pharmacology at the University of Maryland. Her research there focused on the neural mechanisms of complex behaviors and characterization of a genetic model of affective disorders. She also served as Chair of the Graduate Studies and Research Committee and Member of the Dean's Executive Council at the University of Maryland. Currently, Dr. Edwards is also Chair of Women World in Neuroscience (WWN), an independent mentoring and networking organization, with the primary mission of identifying, promoting and implementing mentoring and networking opportunities for women neuroscientists across the world. Charlie Engle Global Ultra-Endurance Athlete • Author • Founder, 5.8 Global Adventure Series Charlie Engle Global Ultra-Endurance Athlete • Author • Founder, 5.8 Global Adventure Series Charlie Engle is a global ultra-endurance athlete and the founder of the 5.8 Global Adventure Series, one of the most ambitious expeditions in modern history, trekking from the lowest to the highest points on all seven continents. He is also one of the most accomplished ultramarathon runners in the world, having placed in hundreds of races in dozens of countries. His incredible athletic ability was profiled in the film, Running the Sahara, narrated by Matt Damon. The documentary highlighted his historic, record-setting journey with his two teammates across the world’s largest desert, running more than two marathons a day for 111 consecutive days, for a total of 4,500 miles. Charlie’s transcontinental run through deep sand and politically unstable countries remains one of the premier accomplishments in the ultra-endurance and adventure sports worlds. After crossing the Sahara and seeing the global water crisis first-hand, Charlie raised more than $6 million for clean water projects in Africa and helped establish an organization called H20Africa, now known as Water.org, one of the largest water nonprofit in the world. Charlie’s memoir, Running Man, became a bestseller shortly after it was published in 2016. While the book details his inspiring life story, it is about more than just running. It is about facing demons, overcoming impossible odds, keeping your sense of humor and discovering the redemptive power of putting one foot in front of the other, even when you feel like you can’t keep going. His motivation to run and tackle extreme adventures stems from his battle with addiction to drugs and alcohol. Charlie has been in recovery since July 23, 1992, and he credits a large part of his recovery to the purposeful devotion and emotional release he experiences while running. He has said that “Drugs and alcohol were my way out. Running was my way through.” Charlie is a dynamic speaker who has enthralled audiences around the world, from keynotes at the Boston Marathon and Google to the National Geographic Society, the United Nations and the deck of a nuclear-class U.S. Naval aircraft carrier. He’s been featured in the New York Times, National Geographic Weekend, Outside, Runner’s World, NPR’s All Things Considered, Men’s Journal, and The Tonight Show with Jay Leno. He lives with his wife, Astacianna Hatcher, in Durham, North Carolina. Chris Evert 18-time Grand Slam Singles Champion • Holder of 3 Doubles Grand Slam Titles • Member of the International Tennis Hall of Fame Chris Evert 18-time Grand Slam Singles Champion • Holder of 3 Doubles Grand Slam Titles • Member of the International Tennis Hall of Fame Chris Evert, one of the most accomplished tennis players in history, burst onto the national tennis scene at the age of 15, and a year later made the 1971 US Open semifinals in her first Grand Slam event. Evert won 18 major singles championships (two Australian Open, three Wimbledon, and a record six US Open and seven French Open titles), winning at least one each year for 13 consecutive years (1974-1986). She retired in 1989 with 157 singles titles overall, and a career win-loss record of 1,309-146 (.900), the best of any professional player in history. She was voted the AP Female Athlete of the Year four times and in 1985 was voted the Greatest Woman Athlete of the Last 25 Years by the Women’s Sports Foundation. She was a unanimous selection to the Tennis Hall of Fame in 1995. In 2019, the USTA Foundation, the national charitable arm of the United States Tennis Association (USTA), appointed Evert as Chair of the USTA Foundation’s Board of Directors. In this role, Evert serves as the Foundation’s spokesperson and ambassador to promote its mission and increase the impact of its national outreach efforts to under-resourced youth. Evert joined ESPN in 2011 as an analyst, and has since covered all four Grand Slam events – including ESPN’s start-to-finish coverage of three Grand Slams – the Australian Open, Wimbledon and the US Open. She also worked as an analyst for NBC for 10 years. Evert operates a tennis academy bearing her name in Boca Raton, Fla., and writes a column for Tennis Magazine. Renée Fleming World Renowned Soprano • Artistic Advisor, Kennedy Center for the Performing Arts Renée Fleming World Renowned Soprano • Artistic Advisor, Kennedy Center for the Performing Arts Renée Fleming is one of the most acclaimed singers of our time. In 2013, President Obama awarded her the National Medal of Arts. In 2014, she became the first classical artist ever to sing the National Anthem at the Super Bowl. Winner of four Grammy® awards, Renée has sung for momentous occasions from the Nobel Peace Prize ceremony to the Diamond Jubilee Concert at Buckingham Palace. Renée’s new album Renée Fleming: Broadway was released in September. She earned a Tony Award nomination for her performance in the 2018 Broadway production of Carousel. She is heard on the soundtracks of the 2018 Best Picture Oscar winner The Shape of Water and Three Billboards Outside Ebbing, Missouri. As Artistic Advisor to the John F. Kennedy Center for the Performing Arts, Renée spearheads a collaboration with the National Institutes of Health and the NEA focused on music, health, and neuroscience. Among her awards are the Fulbright Lifetime Achievement Medal, Germany’s Cross of the Order of Merit, and France’s Chevalier de la Légion d’Honneur. www.reneefleming.com. Chloe Flower Pianist & Composer Chloe Flower Pianist & Composer Energy, fashion, and talent collide every time Chloe Flower sits behind her piano. In February, Chloe’s performance at the 2019 Grammy Awards with Cardi B was a viral sensation. On a mission to make classical music more accessible, Chloe was recently featured on The Today Show and CNN. Her single “Get What U Get” shot to Number 1 on the classical charts. William Frist, MD Partner and Chairman, Cressey & Company Distinguished Executives Council William Frist, MD Partner and Chairman, Cressey & Company Distinguished Executives Council Sandro Galea, MD, MPH, DrPH Dean and Robert A Knox Professor, Boston University School of Public Health Sandro Galea, MD, MPH, DrPH Dean and Robert A Knox Professor, Boston University School of Public Health Sandro Galea, a physician, epidemiologist, and author, is dean and Robert A. Knox Professor at Boston University School of Public Health. He has published 18 books and over 850 peer-review journal articles. He has been listed as one of the world’s most widely cited scholars. He has two children and is a devoted Juventus soccer fan. Patrick Geraghty President & CEO, GuideWell & Florida Blue Patrick Geraghty President & CEO, GuideWell & Florida Blue Pat Geraghty is President and Chief Executive Officer of GuideWell, a $19 billion mutual insurance holding company headquartered in Jacksonville, Fla. A mission-driven health solutions enterprise, GuideWell is the parent to a family of forward-thinking companies focused on transforming health care. It comprises the leading health insurance company in Florida; a consumer engagement and marketing firm; a health care delivery company; a provider of administrative services to federal and state health care programs, including Medicare; and a population health management company. Brett P. Giroir, MD Admiral, U.S. Public Health Service • Assistant Secretary for Health, U.S. Department of Health and Human Services Brett P. Giroir, MD Admiral, U.S. Public Health Service • Assistant Secretary for Health, U.S. Department of Health and Human Services Admiral Brett Giroir is the 16th Assistant Secretary for Health. He serves as the Secretary’s principal public health and science advisor, senior adviser for HRSA, CDC, and SAMHSA and chief opioid policy adviser. He also oversees the Office of the Surgeon General and the U.S. Public Health Service Commissioned Corps. K. Guru Gowrappan, MS CEO, Verizon Media K. Guru Gowrappan, MS CEO, Verizon Media Guru Gowrappan is CEO of Verizon Media, a powerhouse of trusted media and technology brands, including Yahoo, HuffPost, and TechCrunch. Prior to his role at Verizon, he was Global Managing Director of Alibaba where he where he focused on international expansion for key consumer and enterprise products. He has ~20 years of global industry experience building products, operationalizing and scaling businesses across mobile ecosystem and platforms, including commerce & payments, media & gaming, search & utilities, ad products. He has held a breadth of including leadership roles (CEO, COO, CPO) at companies such as Quixey, Zynga, and Overture. He is also a co-founder of two Indian startups. He has an M.S. in computer science from USC and was in the Business bridge program from the Tuck School of Business at Dartmouth. Staci Gruber, PhD, MS, Ed.M, BS, B.Mus. Director, Cognitive & Clinical Neuroimaging Core (CCNC) and the Marijuana Investigations for Neuroscientific Discovery (MIND) Program, McLean Hospital • Associate Professor of Psychiatry, Harvard Medical School Staci Gruber, PhD, MS, Ed.M, BS, B.Mus. Director, Cognitive & Clinical Neuroimaging Core (CCNC) and the Marijuana Investigations for Neuroscientific Discovery (MIND) Program, McLean Hospital • Associate Professor of Psychiatry, Harvard Medical School Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber’s clinical research focuses on the application of neurocognitive models and brain imaging to better characterize risk factors for substance abuse and psychiatric conditions. She has been studying the impact of cannabis on the brain for over two decades using neurocognitive, clinical and diagnostic assessments and multimodal brain imaging techniques. Her work examining the etiologic bases of neural models of dysfunction in cannabis-using adolescents and adults has been published in numerous peer reviewed journals and been the basis of national and international symposia, documentaries, news stories and press conferences, including features in the New York Times, NPR, and CNN’s documentary series “WEED” with Dr. Sanjay Gupta. Her ongoing initiative to educate policymakers, judges, attorneys and the general public about the neurobiologic differences between adults and adolescents as well as additional factors that contribute to the impact of cannabis on the brain have had both local and national impact on policy formation. In fact, Dr. Gruber recently testified at the Senate Caucus on International Narcotics Control hearing entitled, “Marijuana and America’s Health: Questions and Issues for Policy Makers.” Dr. Gruber recognized the importance of examining the impact of medical cannabis use on the brain, as there are many inherent differences between recreational and medical cannabis users. Accordingly, in 2014, Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery (MIND), the first ever program of its kind designed to clarify the specific effects of medical cannabis use. MIND utilizes valid, robust research models and supports numerous projects designed to address the impact of medical cannabis on a number of important variables including cognition, brain structure and function, clinical state, quality of life, pain, sleep, and other health-related measures. As the director of MIND, Dr. Gruber has generated major contributions to the field as the first investigator to assess medical cannabis patients longitudinally, first to acquire neuroimaging data in medical cannabis patients, and as Principal Investigator of the first ever clinical trial of a whole plant-derived, high cannabidiol (CBD) product which she specifically formulated to treat anxiety; other novel clinical trials have been approved and are pending. Sanjay Gupta, MD Chief Medical Correspondent, CNN • Staff Neurosurgeon, Emory University School of Medicine • Associate Chief of Neurosurgery, Grady Memorial Hospital Sanjay Gupta, MD Chief Medical Correspondent, CNN • Staff Neurosurgeon, Emory University School of Medicine • Associate Chief of Neurosurgery, Grady Memorial Hospital Sanjay Gupta is a practicing neurosurgeon and the multiple Emmy® award-winning chief medical correspondent for CNN reporting on health and medical news around the world. He is also a staff neurosurgeon at Emory University School of Medicine, associate chief of neurosurgery at Grady Memorial Hospital, contributor to CBS' news magazine, "60 Minutes," and the author of three New York Timesbest-selling books. Patrice Harris, MD President, American Medical Association Patrice Harris, MD President, American Medical Association Patrice A. Harris, MD, MA, a psychiatrist from Atlanta, became the 174th president of the American Medical Association in June 2019, and the organization’s first African-American woman to hold this position. Dr. Harris has diverse experience as a private practicing physician, public health administrator, patient advocate and medical society lobbyist. Dr. Harris currently spearheads the AMA’s efforts to end the opioid epidemic and has been chair of the AMA Opioid Task Force since its inception in 2014. During her presidency, Dr. Harris will continue to lead the task force as it works across every state to eliminate barriers to treatment, provide patients with access to affordable, non-opioid pain care, and fight the stigma faced by those with substance use-disorders. Having served on the AMA Board of Trustees since 2011, and as chair from 2016 to 2017, she has long been a mentor, a role model and an advocate. Prior to serving on the board, Dr. Harris honed her broad knowledge and deep understanding of health care issues through various leadership roles. At the AMA these included having served for many years on the AMA Council on Legislation, including a term as chair, and on multiple AMA task forces on topics such as health information technology, payment and delivery reform, and private contracting. Beyond the AMA she has held positions of leadership with the American Psychiatric Association, the Georgia Psychiatric Physicians Association, the Medical Association of Georgia, and The Big Cities Health Coalition, where she chaired this forum composed of leaders from America’s largest metropolitan health departments. Growing up in Bluefield, West Virginia, Dr. Harris dreamt of entering medicine at a time when few women of color were encouraged to become physicians. Dr. Harris spent her formative years at West Virginia University, earning a BA in psychology, an MA in counseling psychology and, ultimately, a medical degree in 1992. It was during this time that her passion for helping children emerged, and she completed her psychiatry residency and fellowships in child and adolescent psychiatry and forensic psychiatry at the Emory University School of Medicine. Two themes that govern Dr. Harris’s professional life are a passion to improve the lives of children and service to others. A recognized expert in children’s mental health and childhood trauma, Dr. Harris has led efforts on both local and national levels to integrate public health, behavioral health and primary care services with supports for employment, housing and education. A distinguished fellow of the American Psychiatric Association, Dr. Harris continues in private practice and currently consults with both public and private organizations on health service delivery and emerging trends in practice and health policy. She is an adjunct assistant professor in the Emory Department of Psychiatry and Behavioral Sciences, and an adjunct clinical assistant professor in psychiatry and behavioral sciences at Morehouse School of Medicine. Jerry Harrison, Hon. PhD Co-Founder & Chairman, RedCrow • Founding Member of the Talking Heads Jerry Harrison, Hon. PhD Co-Founder & Chairman, RedCrow • Founding Member of the Talking Heads Jerry Harrison is the Co-Founder and Chairman of RedCrow™ Inc. a direct investment platform presenting professionally vetted investment opportunities in innovative healthcare startups to an accredited crowd of investors. Jerry is also a Co-Founder of Orphirex, Inc. a pioneer in the treatment of snakebites. Prior to RedCrow, Jerry was a Co-Founder of Garage Band, a record label which was a pioneer in using crowd-sourcing and the internet in general to identify promising artists to be signed and then released. Garageband became iLike and was sold to Myspace in 2009. Jerry has served on the Board of Directors for a number of other companies including MicroUnity, IODA and Carbon Gold. Admired for his work as a musician Jerry performed as the keyboard player for The Modern Lovers. Their album recorded in 1972 but released in 1976 was an inspiration to the burgeoning punk rock movement. Also, In 1976, while a student at Harvard’s Graduate School of Design, Jerry met David Byrne, Chris Franz, and Tina Weymouth and left school to join the Talking Heads in January 1977, with whom he remained until the band’s break up in 1991. In 2002, The Talking Heads were inducted into the Rock and Roll Hall of Fame. Jerry has also released several solo albums as well as worked as an active music producer for some of rock and roll’s best-known bands including Live, The Fine Young Cannibals, Violent Femmes, Bodeans, Crash Test Dummies, Kenny Wayne Shepherd Band, No Doubt, Foo Fighters, Verb Pipe and the Von Bondies. A father of three children, he resides in Marin County, California with his wife of 31 years. Mariel Hemingway Author, Actress, & Advocate for Mental Health, Stratosphere Life Foundation Mariel Hemingway Author, Actress, & Advocate for Mental Health, Stratosphere Life Foundation Mariel Hemingway is considered an expert in health—both mental and physical — and is a longtime advocate of personal power, life balance, authenticity, joy and finding peace of mind through a devoted practice of healthy living. She’s both a committed teacher and student in this holistic concentration. In 2014 Mariel co-executive produced the Emmy-nominated Running From Crazy, a rich and evocative documentary about the Hemingway family, collaboration with Oprah Winfrey. The film premiered at the Sundance Film Festival and documents her boundless advocacy for mental health awareness, the dignity and rights of people of all circumstance and ability, and her commitment to connecting those of like mind and heart in order to optimize their lives in the best and worst of times. In May 2015, in alignment with National Mental Health Awareness month, Regan Arts Publishing released two new books including her memoir, “Out Came The Sun” and a young adult targeted diary form project about the journey from surviving to thriving, entitled “Invisible Girl. In 2013, Mariel co-wrote the book, Running With Nature, wherein she and her life partner Bobby Williams share their insights about the import and impact of nutrition, meditation, mindfulness, movement, silence, the beauty of simple living, compassion for self and community, and staying a student of life at all ages. Mariel’s best-selling book, Finding My Balance, is an honest and inspiring story of her life’s journey through the lens of her personal yoga and meditation practices. Her second book, Mariel Hemingway’s Healthy Living from the Inside Out is a how-to guide to finding a greater sense of balance and meaning through self-empowering techniques and strategies. Her 2009 cookbook, Mariel’s Kitchen, offers creative gluten and sugar free recipes and was one of the first to shine the national spotlight on the benefits of this type of diet and lifestyle. Mariel is a regular keynote speaker at conferences, conventions, and on academic panels where those of like mind and heart gather to educate, engage, entertain, and to enrich each other’s experiences. She is also an educator for groundtherapy.com and for Earthing.com which promotes the natural anti inflammatory properties of grounding. She created a magazine dedicated to the practice of grounding called MH Earthing. Recent health, wellness, inspirational, advocacy and entertainment media profiles include those in USA Today, LA Times, The Chicago Tribune, The Times of London, The Today & Dr. Oz shows, Huffington Post/AOL video sites, Vanity Fair, the New York Times, Interview, People, and USA Today Best of Magazines. In 2014, Mariel was the focus of a one-hour interview about her books with Oprah Winfrey’s on OWN’s premiere show, Super Soul Sunday. Mark Hoplamazian President & CEO, Hyatt Hotels Corporation Mark Hoplamazian President & CEO, Hyatt Hotels Corporation Mark Hoplamazian has served as Hyatt’s President and CEO since December 2006, following his appointment to Hyatt’s Board of Directors in November 2006. Prior to joining Hyatt, Mark spent time at the Pritzker Organization, L.L.C where he served as an advisor to various Pritzker family-owned companies, including Hyatt Hotels Corporation. He previously worked at The First Boston Corporation in New York. Patty Horoho, BSN, MSN, MS CEO, OptumServe Patty Horoho, BSN, MSN, MS CEO, OptumServe Patty Horoho is the CEO of OptumServe, which provides technology, health services, data analytics and consulting for the U.S. Departments of Defense, Health and Human Services, Veterans Affairs, and others. After 33 years in the Army, Patty retired as Lieutenant General, the 43rd Army Surgeon General and Commander of the Army Medical Command, the first female and nurse to hold these posts. Meija Jacobs Sr. Director IDEO Design for Food Meija Jacobs Sr. Director IDEO Design for Food Design is Meija's not-so-secret weapon for creating a better food future. Meija brings a background in clinical psychology to design brands, products and experiences—from a communications platform to support former NFL players in healthy behavior change to award-winning wholesome kids snacks. She also serves on the board of Eat Real, a nonprofit tackling diet-related disease by supporting school districts to transform food programs. Paul Jacobs, PhD Chairman & Chief Executive Officer, XCOM Labs Paul Jacobs, PhD Chairman & Chief Executive Officer, XCOM Labs Paul E. Jacobs, Ph.D., founded XCOM in 2018 to #keepinventing and to invest with the world’s most creative engineers and businesspeople. As former chief executive officer and executive chairman of Qualcomm Incorporated, Dr. Jacobs spearheaded its efforts to develop and commercialize fundamental mobile technology breakthroughs that fueled the wireless internet and smartphone revolutions. During his tenure as CEO, Qualcomm’s revenues quadrupled and its market capitalization doubled. Dr. Jacobs is a prolific inventor with over 80 U.S. patents granted or pending in the field of wireless technology and devices. He served as a director of Qualcomm Incorporated from June 2005 to March 2018, including as chairman of the board of directors from March 2009 to March 2018, and as executive chairman from March 2014 to March 2018. He served as chief executive officer from July 2005 to March 2014, and as group president of Qualcomm Wireless & Internet from July 2001 to July 2005. In addition, he served as an executive vice president of Qualcomm Incorporated from February 2000 to June 2005. Dr. Jacobs is a director of Dropbox, Inc. and FIRST, and Chairman of Heal, a private technology enabled medical care company. He is an owner and vice chairman of the Sacramento Kings, who compete in the National Basketball Association (NBA). He attended the University of California, Berkeley, where he earned a B.S. in electrical engineering and computer science, M.S. in electrical engineering, and Ph.D. in electrical engineering and computer science. He founded Berkeley’s Jacobs Institute for Design Innovation and was the university’s 2017 Alumnus of the Year. Dr. Jacobs is a member of the National Academy of Engineering and a Fellow of the American Academy of Arts and Sciences. Carl H. June, MD Richard W. Vague Professor in Immunotherapy, Perelman School of Medicine, University of Pennsylvania • Director, Center for Cellular Immunotherapies • Director, Parker Institute for Cancer Immunotherapy Carl H. June, MD Richard W. Vague Professor in Immunotherapy, Perelman School of Medicine, University of Pennsylvania • Director, Center for Cellular Immunotherapies • Director, Parker Institute for Cancer Immunotherapy Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well-known for his research into T cell therapies for the treatment of cancer. Dean Kamen President, DEKA Research & Development Dean Kamen President, DEKA Research & Development Dean Kamen is an inventor, an entrepreneur, and a tireless advocate for science and technology. His roles as inventor and advocate are intertwined—his own passion for technology and its practical uses has driven his personal determination to spread the word about technology's virtues and by so doing to change the culture of the United States. As an inventor, he holds more than 440 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of health care worldwide. While still a college undergraduate, he invented the first wearable infusion pump, which rapidly gained acceptance from such diverse medical specialties as oncology, neonatology, and endocrinology. In 1976, he founded his first medical device company, AutoSyringe, Inc., to manufacture and market the pumps. Then, working with leading diabetes researchers, Dean pioneered the design and adoption of the first portable insulin pump. It was quickly demonstrated that using a pump could much more effectively control patients’ blood glucose levels. . At age 30, he sold AutoSyringe to Baxter Healthcare Corporation. Following the sale of AutoSyringe, Inc., he founded DEKA Research & Development Corporation to develop internally generated inventions as well as to provide research and development for major corporate clients. Kamen led DEKA's development of the HomeChoiceTM peritoneal dialysis system for Baxter International Inc. The HomeChoiceTM system allows patients to be dialyzed in the privacy and comfort of their home and quickly became the worldwide market leader. Kamen also led the development of technology to improve slide preparation for the CYTYC (now Hologic Inc.) ThinPrep® Pap Test. Kamen-led DEKA teams have also developed critical components of the UVARTM XTSTM System, an extracorporeal photophereisis device marketed by Therakos, a unit of Johnson & Johnson, for treatment of T-Cell lymphoma. An advanced prosthetic arm in development for DARPA should advance the quality of life for returning injured soldiers. Other notable developments include the HydroflexTM surgical irrigation pump for C.R. Bard, the CrownTM stent, an improvement to the original Palmaz-Schatz stent, for Johnson & Johnson, the iBOTTM mobility device, and the Segway® Human Transporter. Kamen has received many awards for his efforts. Notably, Kamen was awarded the National Medal of Technology in 2000. Presented by President Clinton, this award was in recognition for inventions that have advanced medical care worldwide, and for innovative and imaginative leadership in awakening America to the excitement of science and technology. Kamen was elected a member of the National Academy of Engineering in 1997. He was awarded the Lemelson-MIT Prize in 2002, and was inducted into the National Inventors Hall of Fame in May 2005. He is a Fellow of the American Institute for Medical & Biological Engineering, as well as many other national and international engineering organizations. In addition to DEKA, one of Dean's proudest accomplishments is founding FIRST® (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to understand, use and enjoy science and technology. Founded in 1989, this year FIRST® will serve more than 1,000,000 young people, ages 6 to 18, in more than 86 countries around the globe. Last year, high-school-aged participants were eligible to apply for more than $50 million in scholarships from over 200 leading colleges, universities, and corporations.